In this study, we demonstrated that KIF4A is abundantly expressed in bladder cancer, and the high expression of KIF4A has been significantly correlated with fewer CD8 + tumor-infiltrating lymphocytes (TILs) and poorer prognosis in BC patients. Here, KIF4A is linked to urinary bladder cancer.